Viral Hepatitis
Copyright ©The Author(s) 2004.
World J Gastroenterol. Apr 1, 2004; 10(7): 972-976
Published online Apr 1, 2004. doi: 10.3748/wjg.v10.i7.972
Table 4 Sequential changes and comparisons of serum ferritin levels (μg/L) at different time points during lamivudine treatment in patients with normalized serum ALT and those with abnormal ALT at end of treatment
GroupBaselineMonths after treatment
3612
HBV DNA ( - ) group (n = 19)198.40 ± 161.58139.39 ± 111.3112.35 ± 57.5199.19 ± 60.52
HBV DNA ( + ) group (n = 19)220.22 ± 136.72173.56 ± 109.68140.37 ± 86.07155.21 ± 98.94
P values0.6560.3470.2660.048